| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |